2 results
Approved WMOCompleted
HV cohort 1Primary Objectives* To characterize the local tolerability of topical bimiralisib after 21 days* To characterize the systemic PK of topical bimiralisib after 21 daysSecondary Objective* To characterize the safety of topical bimiralisib…
Approved WMORecruiting
The purpose of this study is to demonstrate the efficacy of 9-valentextraintestinal pathogenic Escherichia coli vaccine (ExPEC9V) compared toplacebo in the prevention of the first invasive extraintestinal pathogenicEscherichia coli disease (IED)…